cbdMD (YCBD) Intangibles (2016 - 2025)
cbdMD (YCBD) reported Intangibles of $1.9 million for Q4 2025, down 28.35% on a YoY basis from $2.7 million in Q4 2024, and down 9.0% sequentially from $2.1 million in Q3 2025.
cbdMD (YCBD) Intangibles (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Intangibles data on file, last reported at $1.9 million in Q4 2025.
- For the quarter ending Q4 2025, Intangibles fell 28.35% year-over-year to $1.9 million; the trailing twelve-month figure through Dec 2025 stood at $1.9 million (down 28.35% YoY), and the FY2025 full-year result was $2.1 million, down 26.48% from the prior year.
- Intangibles fell to $1.9 million in Q4 2025, from $2.1 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $23.0 million in Q3 2021 to a low of $1.9 million in Q4 2025.
- A 5-year average of $10.9 million and a median of $10.1 million in 2023 frame the typical range for Intangibles.
- Across the five-year window, Intangibles advanced 6.33% in 2021 and sank 84.12% in 2024, its largest moves.
- Tracing YCBD's Intangibles over 5 years: stood at $18.7 million in 2021, then retreated by 5.94% to $17.6 million in 2022, then sank by 82.65% to $3.0 million in 2023, then slipped by 11.42% to $2.7 million in 2024, then dropped by 28.35% to $1.9 million in 2025.
- Business Quant data shows YCBD's Intangibles at $1.9 million in Q4 2025, $2.1 million in Q3 2025, and $2.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 34.07 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 3.61 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 959.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 21.80 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 473.93 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.48 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.23 Bn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 1.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 2.12 Mn |
| Jun 30, 2025 | 2.32 Mn |
| Mar 31, 2025 | 2.51 Mn |
| Dec 31, 2024 | 2.70 Mn |
| Sep 30, 2024 | 2.89 Mn |
| Jun 30, 2024 | 2.70 Mn |
| Mar 31, 2024 | 2.87 Mn |
| Dec 31, 2023 | 3.05 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 17.00 Mn |
| Mar 31, 2023 | 17.28 Mn |
| Dec 31, 2022 | 17.56 Mn |
| Sep 30, 2022 | 17.83 Mn |
| Jun 30, 2022 | 18.11 Mn |
| Mar 31, 2022 | 18.39 Mn |
| Dec 31, 2021 | 18.67 Mn |
| Sep 30, 2021 | 23.00 Mn |
| Jun 30, 2021 | 21.64 Mn |
| Mar 31, 2021 | 21.64 Mn |